Analysts Conflicted on These Healthcare Names: Axsome Therapeutics (AXSM), Waters (WAT) and Cingulate Inc (CING)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Axsome Therapeutics (AXSM – Research Report), Waters (WAT – Research Report) and Cingulate Inc (CING – Research Report).
Confident Investing Starts Here:
Axsome Therapeutics (AXSM)
In a report issued on May 16, Vikram Purohit from Morgan Stanley maintained a Buy rating on Axsome Therapeutics, with a price target of $190.00. The company's shares closed last Friday at $107.53.
According to TipRanks.com, Purohit 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -7.5% and a 30.9% success rate. Purohit covers the Healthcare sector, focusing on stocks such as Recursion Pharmaceuticals, BioMarin Pharmaceutical, and Arcutis Biotherapeutics.
Currently, the analyst consensus on Axsome Therapeutics is a Strong Buy with an average price target of $177.85, a 66.6% upside from current levels. In a report issued on May 1, Mizuho Securities also maintained a Buy rating on the stock with a $210.00 price target.
Waters (WAT)
Bank of America Securities analyst Michael Ryskin reiterated a Hold rating on Waters yesterday and set a price target of $370.00. The company's shares closed last Friday at $359.48.
According to TipRanks.com, Ryskin is a 2-star analyst with an average return of 0.2% and a 45.0% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, West Pharmaceutical Services, and Fortrea Holdings Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Waters with a $393.77 average price target, representing an 11.9% upside. In a report issued on May 6, TD Cowen also maintained a Hold rating on the stock with a $375.00 price target.
Cingulate Inc (CING)
In a report released yesterday, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Cingulate Inc, with a price target of $11.00. The company's shares closed last Friday at $3.82, close to its 52-week low of $1.80.
According to TipRanks.com, Pachaiyappan has 0 stars on 0-5 stars ranking scale with an average return of -9.8% and a 31.5% success rate. Pachaiyappan covers the Healthcare sector, focusing on stocks such as Reviva Pharmaceuticals Holdings, Entrada Therapeutics Inc, and Gain Therapeutics.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 days ago
- Business Insider
Analysts Are Bullish on Top Technology Stocks: Logitech (LOGI), Adeia (ADEA)
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Logitech (LOGI – Research Report) and Adeia (ADEA – Research Report) with bullish sentiments. Confident Investing Starts Here: Logitech (LOGI) Kepler Capital analyst Torsten Sauter maintained a Buy rating on Logitech on June 18 and set a price target of CHF88.00. The company's shares closed last Wednesday at $84.51. According to Sauter is ranked #2194 out of 9636 analysts. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Logitech with a $88.29 average price target. Adeia (ADEA) In a report released today, Scott Searle from Roth MKM initiated coverage with a Buy rating on Adeia and a price target of $26.00. The company's shares closed last Wednesday at $13.06. According to Searle is a 5-star analyst with an average return of 12.4% and a 48.7% success rate. Searle covers the Technology sector, focusing on stocks such as Sequans Communications S A, Digi International, and Universal Display. Adeia has an analyst consensus of Strong Buy, with a price target consensus of $17.33.
Business Insider
2 days ago
- Business Insider
Analysts Offer Insights on Financial Companies: ANZ Group Holdings (OtherANZGF) and Suncorp Group (OtherSNMYF)
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on ANZ Group Holdings (ANZGF – Research Report) and Suncorp Group (SNMYF – Research Report). Confident Investing Starts Here: ANZ Group Holdings (ANZGF) In a report released today, Richard Wiles from Morgan Stanley maintained a Hold rating on ANZ Group Holdings, with a price target of A$26.50. The company's shares closed last Friday at $18.60. According to Wiles ' ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -8.8% and a 30.4% success rate. Wiles covers the Financial sector, focusing on stocks such as National Australia Bank Limited, Bendigo & Adelaide Bank, and Bank of Queensland. Currently, the analyst consensus on ANZ Group Holdings is a Hold with an average price target of $18.18, a -2.3% downside from current levels. In a report issued on June 16, Citi also maintained a Hold rating on the stock with a A$27.50 price target. Suncorp Group (SNMYF) In a report released today, Andrei Stadnik from Morgan Stanley maintained a Buy rating on Suncorp Group, with a price target of A$25.00. The company's shares closed last Friday at $13.81. According to Stadnik is a 4-star analyst with an average return of 6.7% and a 55.3% success rate. Stadnik covers the Financial sector, focusing on stocks such as Insurance Australia Group Limited, QBE Insurance Group Limited, and Macquarie Group Limited. Suncorp Group has an analyst consensus of Moderate Buy, with a price target consensus of $14.18.
Business Insider
3 days ago
- Business Insider
Analysts Offer Insights on Materials Companies: Bluescope Steel (OtherBLSFF) and Northern Star Resources Ltd (OtherNESRF)
Analysts have been eager to weigh in on the Materials sector with new ratings on Bluescope Steel (BLSFF – Research Report) and Northern Star Resources Ltd (NESRF – Research Report). Confident Investing Starts Here: Bluescope Steel (BLSFF) In a report released today, Rohan Gallagher from Jarden maintained a Buy rating on Bluescope Steel, with a price target of A$25.30. The company's shares closed last Monday at $15.07. According to Gallagher is a 4-star analyst with an average return of 8.9% and a 56.3% success rate. Gallagher covers the Basic Materials sector, focusing on stocks such as Brickworks Ltd, James Hardie, and Sims. Currently, the analyst consensus on Bluescope Steel is a Strong Buy with an average price target of $17.76, which is a 31.1% upside from current levels. In a report issued on June 10, Jefferies also maintained a Buy rating on the stock with a A$29.00 price target. Northern Star Resources Ltd (NESRF) Jarden analyst Ben Lyons maintained a Hold rating on Northern Star Resources Ltd yesterday and set a price target of A$19.40. The company's shares closed last Wednesday at $13.86. According to Lyons is a 4-star analyst with an average return of 9.4% and a 69.3% success rate. Lyons covers the Basic Materials sector, focusing on stocks such as Sandfire Resources Limited, Mineral Resources Limited, and Pilbara Minerals. Currently, the analyst consensus on Northern Star Resources Ltd is a Moderate Buy with an average price target of $14.97, which is a 6.4% upside from current levels. In a report issued on June 16, UBS also downgraded the stock to Hold with a A$23.00 price target.
